SZL P1-41, a skp2 inhibitor, can prevent assembly of Skp2-Skp1 complexes. It selectively suppresses Skp2 SCF E3 ligase activity but exhibits no effect on the activity of other SCF complexes. It also inhibits Skp2-mediated p27 and Akt ubiquitination in vivo and in vitro. It suppresses the survival of Y cells and Y stem cells by […]
More Information Supplier Page
SZL P1-41, a skp2 inhibitor, can prevent assembly of Skp2-Skp1 complexes. It selectively suppresses Skp2 SCF E3 ligase activity but exhibits no effect on the activity of other SCF complexes. It also inhibits Skp2-mediated p27 and Akt ubiquitination in vivo and in vitro. It suppresses the survival of Y cells and Y stem cells by […]
More Information Supplier Page SZL P1-41, a skp2 inhibitor, can prevent assembly of Skp2-Skp1 complexes. It selectively suppresses Skp2 SCF E3 ligase activity but exhibits no effect on the activity of other SCF complexes. It also inhibits Skp2-mediated p27 and Akt ubiquitination in vivo and in vitro. It suppresses the survival of Y cells and Y stem cells by […]
More Information Supplier Page 
Ceralasertib (AZD6738) is an orally active, and selective ATR kinase inhibitor with IC50 of 1 nM.
More Information Supplier Page
Ceralasertib (AZD6738) is an orally active, and selective ATR kinase inhibitor with IC50 of 1 nM.
More Information Supplier Page
Ceralasertib (AZD6738) is an orally active, and selective ATR kinase inhibitor with IC50 of 1 nM.
More Information Supplier Page 
Verteporfin, a benzoporphyrin derivative monoacid ring A, can inhibit the activity of YAP.
More Information Supplier Page
Verteporfin, a benzoporphyrin derivative monoacid ring A, can inhibit the activity of YAP.
More Information Supplier Page Verteporfin, a benzoporphyrin derivative monoacid ring A, can inhibit the activity of YAP.
More Information Supplier Page Verteporfin, a benzoporphyrin derivative monoacid ring A, can inhibit the activity of YAP.
More Information Supplier Page 
